Anzahl der Publikationen: 19
2023
Fuchs, Michael
ORCID: https://orcid.org/0000-0002-7816-3438; Radeva, Mariya Y.
ORCID: https://orcid.org/0000-0002-9902-1682; Spindler, Volker; Vielmuth, Franziska
ORCID: https://orcid.org/0000-0002-8570-7595; Kugelmann, Daniela
ORCID: https://orcid.org/0000-0002-2512-4240 und Waschke, Jens
ORCID: https://orcid.org/0000-0003-1182-5422
(2023):
Cytoskeletal anchorage of different Dsg3 pools revealed by combination of hybrid STED/SMFS-AFM.
In: Cellular and Molecular Life Sciences, Bd. 80, Nr. 1, 25
[PDF, 17MB]
2022
Gillessen, Sarah; Pluetschow, Annette; Vucinic, Vladan; Ostermann, Helmut; Kobe, Carsten; Broeckelmann, Paul J.; Boell, Boris; Eichenauer, Dennis A.; Heger, Jan-Michel; Borchmann, Sven; Fuchs, Michael; Borchmann, Peter; Engert, Andreas und Tresckow, Bastian von
(2022):
JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO).
In: European Journal of Haematology, Bd. 109, Nr. 6: S. 728-735
Jacob, Anne Sophie; Kaul, Helen; Fuchs, Michael; Gillessen, Sarah; Kreissl, Stefanie; Pluetschow, Annette; Momotow, Jesko; Schaub, Valdete; Huettmann, Andreas; Haenel, Mathias; Zimmermann, Andreas; Dierlamm, Judith; Meissner, Julia; Mathas, Stephan; Martin, Sonja; Engert, Andreas; Hallek, Michael; Borchmann, Peter und Lehmann, Clara
(2022):
Impact of the first COVID-19 lockdown in Germany on the rate of acute infections during intensive chemotherapy for Hodgkin lymphoma.
In: Infection, Bd. 50, Nr. 4: S. 925-932
2021
Kreissl, Stefanie; Goergen, Helen; Buehnen, Ina; Kobe, Carsten; Moccia, Alden; Greil, Richard; Eichenauer, Dennis A.; Zijlstr, Josee M.; Markova, Jana; Meissner, Julia; Feuring-Buske, Michaela; Soekler, Martin; Beck, Hans Joachim; Willenbacher, Wolfgang; Ludwig, Wol-Dieter; Pabst, Thomas; Topp, Max S.; Hitz, Felicitas; Bentz, Martin; Keller, Ulrich Bernd; Kuehnhardt, Dagmar; Ostermann, Helmut; Hertenstein, Bernd; Ulitzky, Wafter A.; Maschmeyer, Georg; Vieler, Tons; Eich, Hans; Baues, Christian; Stein, Harald; Fuchs, Michael; Diehl, Volker; Dietlein, Markus; Engert, Andreas und Borchmann, Peter
(2021):
PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial.
In: Lancet Haematology, Bd. 8, Nr. 6, E398-E409
Borchmann, Peter; Plutschow, Annette; Kobe, Carsten; Greil, Richard; Meissner, Julia; Topp, Max S.; Ostermann, Helmut; Dierlamm, Judith; Mohm, Johannes; Thiemer, Julia; Sokler, Martin; Kerkhoff, Andrea; Ahlborn, Miriam; Halbsguth, Teresa V.; Martin, Sonja; Keller, Ulrich; Balabanov, Stefan; Pabst, Thomas; Vogelhuber, Martin; Huttmann, Andreas; Wilhelm, Martin; Zijlstra, Josee M.; Moccia, Alden; Kuhnert, Georg; Brockelmann, Paul J.; Tresckow, Bastian von; Fuchs, Michael; Klimm, Beate; Rosenwald, Andreas; Eich, Hans; Baues, Christian; Marnitz, Simone; Hallek, Michael; Diehl, Volker; Dietlein, Markus und Engert, Andreas
(2021):
PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17) : a multicentre, open-label, randomised, phase 3 trial.
In: Lancet Oncology, Bd. 22, Nr. 2: S. 223-234
2020
Broeckelmann, Paul J.; Goergen, Helen; Keller, Ulrich; Meissner, Julia; Ordemann, Rainer; Halbsguth, Teresa V.; Sasse, Stephanie; Soekler, Martin; Kerkhoff, Andrea; Mathas, Stephan; Huettmann, Andreas; Bormann, Matthias; Zimmermann, Andreas; Mettler, Jasmin; Fuchs, Michael; Tresckow, Bastian von; Baues, Christian; Rosenwald, Andreas; Klapper, Wolfram; Kobe, Carsten; Borchmann, Peter und Engert, Andreas
(2020):
Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial.
In: Jama Oncology, Bd. 6, Nr. 6: S. 872-880
2019
Fuchs, Michael; Foresti, Marco; Radeva, Mariya Y.; Kugelmann, Daniela; Keil, Rene; Hatzfeld, Mechthild; Spindler, Volker; Waschke, Jens und Vielmuth, Franziska
(2019):
Plakophilin 1 but not plakophilin 3 regulates desmoglein clustering.
In: Cellular and Molecular Life Sciences, Bd. 76, Nr. 17: S. 3465-3476
2018
Vielmuth, Franziska; Walter, Elias; Fuchs, Michael; Radeva, Mariya Y.; Buechau, Fanny; Magin, Thomas M.; Spindler, Volker und Waschke, Jens
(2018):
Keratins Regulate p38MaPK-Dependent Desmoglein Binding Properties in Pemphigus.
In: Frontiers in Immunology, Bd. 9, 528
[PDF, 13MB]
2017
Saake, Irmhild
(2017):
Alternsforschung. Entwicklung und Tendenzen.
In: Fuchs, Michael (Hrsg.):
Handbuch Alter und Altern. Anthropologie - Kultur - Ethik. 1. Auflage 2018. Stuttgart: J.B. Metzler, Part of Springer Nature - Springer-Verlag GmbH.
Eichenauer, Dennis A.; Plütschow, Annette; Kreissl, Stefanie; Sökler, Martin; Hellmuth, Johannes C.; Meissner, Julia; Mathas, Stephan; Topp, Max S.; Behringer, Karolin; Klapper, Wolfram; Kuhnert, Georg; Dietlein, Markus; Kobe, Carsten; Fuchs, Michael; Diehl, Volker; Engert, Andreas und Borchmann, Peter
(2017):
Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group.
In: Lancet Oncology, Bd. 18, Nr. 12: S. 1680-1687
Borchmann, Peter; Haverkamp, Heinz; Lohri, Andreas; Mey, Ulrich; Kreissl, Stefanie; Greil, Richard; Markova, Jana; Feuring-Buske, Michaela; Meissner, Julia; Duehrsen, Ulrich; Ostermann, Helmut; Keller, Ulrich; Maschmeyer, Georg; Kuhnert, Georg; Dietlein, Markus; Kobe, Carsten; Eich, Hans; Baues, Christian; Stein, Harald; Fuchs, Michael; Diehl, Volker und Engert, Andreas
(2017):
Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP(escalated) alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group.
In: Lancet Oncology, Bd. 18, Nr. 4: S. 454-463
Borchmann, Peter; Goergen, Helen; Kobe, Carsten; Lohri, Andreas; Greil, Richard; Eichenauer, Dennis A.; Zijlstra, Josee M.; Markova, Jana; Meissner, Julia; Feuring-Buske, Michaela; Hüttmann, Andreas; Dierlamm, Judith; Sökler, Martin; Beck, Hans-Joachim; Willenbacher, Wolfgang; Ludwig, Wolf-Dieter; Pabst, Thomas; Topp, Max S.; Hitz, Felicitas; Bentz, Martin; Keller, Ulrich Bernd; Kuhnhardt, Dagmar; Ostermann, Helmut; Schmitz, Norbert; Hertenstein, Bernd; Aulitzky, Walter; Maschmeyer, Georg; Vieler, Tom; Eich, Hans; Baues, Christian; Stein, Harald; Fuchs, Michael; Kuhnert, Georg; Diehl, Volker; Dietlein, Markus und Engert, Andreas
(2017):
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
In: Lancet, Bd. 390, Nr. 10114: S. 2790-2802
2015
2014
Diese Liste wurde am
Sun Aug 4 02:52:44 2024 CEST
erstellt.